A Study of LY3473329 in Participants With Impaired and Normal Renal Function

NCT05778864 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency

Interventions

DRUG: LY3473329

Sponsor

Eli Lilly and Company